1. Home
  2. REFI vs CCCC Comparison

REFI vs CCCC Comparison

Compare REFI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFI
  • CCCC
  • Stock Information
  • Founded
  • REFI 2021
  • CCCC 2015
  • Country
  • REFI United States
  • CCCC United States
  • Employees
  • REFI N/A
  • CCCC N/A
  • Industry
  • REFI Real Estate Investment Trusts
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • REFI Real Estate
  • CCCC Health Care
  • Exchange
  • REFI Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • REFI 306.0M
  • CCCC 304.8M
  • IPO Year
  • REFI 2021
  • CCCC 2020
  • Fundamental
  • Price
  • REFI $16.02
  • CCCC $6.03
  • Analyst Decision
  • REFI Buy
  • CCCC Buy
  • Analyst Count
  • REFI 4
  • CCCC 7
  • Target Price
  • REFI $17.33
  • CCCC $8.71
  • AVG Volume (30 Days)
  • REFI 114.0K
  • CCCC 2.6M
  • Earning Date
  • REFI 08-07-2024
  • CCCC 08-06-2024
  • Dividend Yield
  • REFI 11.73%
  • CCCC N/A
  • EPS Growth
  • REFI 0.51
  • CCCC N/A
  • EPS
  • REFI 1.99
  • CCCC N/A
  • Revenue
  • REFI $55,477,705.00
  • CCCC $20,036,000.00
  • Revenue This Year
  • REFI $15.73
  • CCCC $26.24
  • Revenue Next Year
  • REFI $7.11
  • CCCC N/A
  • P/E Ratio
  • REFI $8.05
  • CCCC N/A
  • Revenue Growth
  • REFI 2.73
  • CCCC N/A
  • 52 Week Low
  • REFI $13.86
  • CCCC $1.06
  • 52 Week High
  • REFI $17.65
  • CCCC $11.88
  • Technical
  • Relative Strength Index (RSI)
  • REFI 58.46
  • CCCC 57.54
  • Support Level
  • REFI $15.17
  • CCCC $4.36
  • Resistance Level
  • REFI $16.47
  • CCCC $7.66
  • Average True Range (ATR)
  • REFI 0.28
  • CCCC 0.56
  • MACD
  • REFI 0.09
  • CCCC 0.21
  • Stochastic Oscillator
  • REFI 69.80
  • CCCC 50.68

About REFI Chicago Atlantic Real Estate Finance Inc.

Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Share on Social Networks: